Development of a new 15-valent pneumococcal conjugate vaccine (PCV15) and evaluation of its immunogenicity.

In this study, we propose a new PCV15 candidate, in which the common 13 serotypes and a licensed control vaccine have equivalent efficacy while two additional serotypes showed adequate immunogenicity in the rabbit model.
PMID: 31416790 [PubMed - as supplied by publisher]

Source: Biologicals : Journal of the International Association of Biological Standardization - August 11, 2019 Category: Biotechnology Authors: Lee C, Choi SK, Kim RK, Kim H, Whang YH, Pharm H, Cheon H, Yoon DY, Kim CW, Baik YO, Park SS, Lee I Tags: Biologicals Source Type: research